Search online for information about in vitro fertilization (IVF), and you’ll run into a long list of complementary services, or “add-ons” each with a different price tag.

Assisted hatching, enriched culture media, implantation window testing, immune therapies. The list of IVF add-ons grows every year. So does the confusion about which ones actually change the outcome of a cycle.

Each additional test can add anywhere from a modest fee to an amount comparable to the base treatment itself.

The real question isn’t whether an add-on works in general. It’s whether it answers a crucial unknown in your specific case.

What Is an IVF Add-On, and Why Does It Exist?

An add-on is any test, medication, or technology offered on top of the standard IVF protocol, which is known in reproductive medicine as a complementary service.

None of these comes out of nowhere. Each one responds to a clinical problem identified through reproductive research. They’re not decoration for your treatment.

An add-on backed by real evidence isn’t a luxury. It answers a specific medical question. One without evidence, offered generically, only adds variables without adding useful information.

Before agreeing to any add-on, three questions are worth asking. Is there a concrete clinical reason in my history to add this? What evidence supports this test for my specific situation, not in general? Are they explaining why I need it, or just telling me it’s available?

Evidence-Backed IVF Add-Ons, Depending on Your Case

These are tests that Nascere activates when the case calls for them. Each one answers a different question.

Sperm DNA Fragmentation Testing

This test evaluates the male factor beyond a standard semen analysis. It detects genetic damage in the sperm that a basic test won’t reveal. It helps when the eggs and embryo development look normal, but cycles still aren’t moving forward. That’s often where the male factor turns out to be the missing piece.

The male factor shows up in a significant share of infertility cases and deserves the same weight as the female factor in any serious diagnosis.

Endometrial Microbiome Testing

This test rules out pathogens or uterine infections that can interfere with implantation. It’s a different test from implantation window testing: one looks for infection, the other looks for the optimal moment. Confusing the two can mean treating the wrong problem.

A silent infection can show no symptoms at all and still interfere with embryo implantation.

Immunological Panel

This test identifies an immune response that can interfere with embryo implantation. It makes sense when there’s a history of recurrent pregnancy loss or implantation failure with no other identified cause.

Clinics activate it when the clinical history calls for it, not as a standard package for every patient who walks into a consultation, and not as a routine test in a first cycle.

Implantation Window Analysis

This test identifies the exact moment when each patient’s endometrium is ready to receive the embryo, because that moment isn’t the same for everyone. Real evidence supports this test in patients with recurrent implantation failure (previous transfers of genetically normal embryos that failed to implant).

There’s no evidence that it adds the same value when applied from the first cycle to any patient. Here, the protocol adapts to the case, never the other way around. It’s the clearest example of an add-on that only makes sense when the case calls for it. Applied at the right time, it provides real information. Applied unnecessarily, it changes nothing.

Embryo Genetic Testing (PGT-A)

This test evaluates the embryo’s specific genetic makeup, even when neither parent has a diagnosed genetic condition. The embryo, formed from both parents’ gametes, is a distinct entity that requires its own evaluation.

It detects chromosomal abnormalities, the most common reason an embryo fails to implant or a pregnancy is lost early on, regardless of how normal the embryo looks under a microscope. At Nascere, it’s part of the standard protocol for every patient, because applying it from the start helps avoid transferring an embryo with abnormalities that would lead to a failed cycle or a pregnancy loss.

For recurrent pregnancy loss or repeated implantation failure, there’s an expanded version, PGT-A Plus, designed to investigate those scenarios in greater depth.

IVF Add-Ons Without Solid Evidence Behind Them

Not every add-on on a treatment estimate carries the same level of support. They tend to show up as appealing options, with technical names that sound like innovation.

Clinics offer some of these broadly, without consistent evidence that they improve outcomes:

• Immune therapies prescribed without a prior immune diagnosis to justify them.
• Implantation window testing offered to any patient from the first cycle, with no prior implantation failure.
• Lab culture additives or media with no benefit consistently proven in controlled studies.
• Ovarian “rejuvenation” supplements or therapies without solid clinical backing.

None of these add-ons is automatically harmful. The problem is selling them as if they applied to any patient, when the real evidence only supports their use in specific cases, or doesn’t support them at all.

Other Add-Ons: Surgeries That Complement Your Fertility Treatment

Not every add-on is a lab test. Some are surgical procedures, and most pelvic surgeries within a fertility treatment happen for reproductive or health reasons, not as routine.

• Laparoscopy: This is the technique, not a surgery with a purpose of its own. Minimally invasive, with a shorter recovery than open surgery, it’s what usually makes the procedures below possible, including ones that involve delicate structures like the fallopian tubes.
• Myomectomy: Removes fibroids from the uterine cavity. In many cases, it improves both the chances of a healthy pregnancy and overall quality of life.
• Varicocelectomy: Corrects a varicocele when it’s interfering with sperm quality.
• Tubal reanastomosis (tubal reversal): Reopens or reconnects the fallopian tubes in patients pursuing a natural pregnancy, after an intentional blockage, such as bilateral tubal occlusion (BTO), or an unintentional one, such as a consequence of salpingitis.

Let’s be clear: a reanastomosis never guarantees restored fertility for a patient affected by salpingitis, BTO, or salpingectomy. It’s an option, not a promise.

Published evidence shows outcomes vary widely depending on two factors: the patient’s age at the time of surgery, and the type of prior blockage. Younger age and simpler blockages tend to mean higher odds; older age or more extensive blockages tend to lower them considerably.

Why the Same Test Doesn’t Mean the Same Thing at Every Clinic

Two clinics can offer a test with the same name and very different results.

The team interpreting the results, the lab processing them, and whether the protocol is reproducible determine whether that test actually helps you decide something, or is just another line on the estimate.

A certified lab, a validated protocol, and a team that stays current with the latest evidence aren’t a minor detail. They’re the difference between a result you can trust and one you can’t reproduce.

A thorough fertility diagnosis before adding any add-on reduces unnecessary attempts. It protects the patient physically, emotionally, and financially.

How to Know If an Add-On Actually Helps Your IVF Cycle

The answer doesn’t depend on the test’s name. It depends on your case: before adding it to your treatment, confirm there’s a clinical reason behind it, that the evidence supports it for your specific situation, and that your clinic explains why you need it, not just what it is.

A clinic that answers that question before offering you an add-on is thinking about your case first. IVF doesn’t have to become a shopping list: with the right diagnosis, every test you add has a reason to be there.

A Well-Chosen Add-On Can Change the Outcome of an IVF Cycle

All of this matters even more after a cycle that didn’t work out. A failed cycle doesn’t have to be the end of the story, even if it feels that way in the moment.

Every stage of the process, egg quality, how the embryos developed, leaves information about where things stopped.

Knowing how to use that information means identifying the exact stage and having the right tool to investigate it thoroughly. Without that analysis, the cycle repeats itself instead of revealing what to adjust next time.

Many patients reach this point without ever having had a complete diagnosis, or without access to the technology that would have caught what was really happening in their case. That’s where the right add-on stops being an extra expense.

The male factor test that never happened. The immune panel that explains a recurrent loss. The implantation window analysis that confirms the timing of the transfer, not the embryo, was what needed adjusting; that’s what can complete what a previous cycle left unresolved.

No single complementary service can promise a pregnancy on its own. Applied at the right time, alongside a sound IVF protocol and strategy, it can be the difference between repeating the same cycle without answers and finally addressing what was really getting in the way.